Loading...

Yubo International Biotech Limited

YBGJ•PNK
Healthcare
Medical - Instruments & Supplies
$0.09
$0.00(0.44%)

Yubo International Biotech Limited (YBGJ) Stock Overview

Explore Yubo International Biotech Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap12M
P/E Ratio-9.96
EPS (TTM)$-0.02
ROE3.46%
Fundamental Analysis

AI Price Forecasts

1 Week$0.07
1 Month$0.00
3 Months$0.00
1 Year Target$0.24

YBGJ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Yubo International Biotech Limited (YBGJ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.57, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.96 and a market capitalization of 12M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

48.57RSI (14)
0.00MACD
17.87ADX
Stats data is not available for YBGJStats details for YBGJ are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for YBGJAnalyst Recommendations details for YBGJ are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Yubo International Biotech Limited, thorough its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is based in Beijing, China.

CEO

Yang Wang

Employees

18

Headquarters

Building 5, Beijing

Founded

2021

Frequently Asked Questions

;